Selman Renee

Avg. Two Year Performance

(62%) Avg. Purchase Return
(27%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return3%(7%)25%(34%)(62%)
Purchase Success Rate2 of 21 of 22 of 20 of 20 of 2
Average Sale Return----------
Sale Success Rate----------

Agile Therapeutics, Inc.

Drugs » Drugs - Generic

Chief Commercial Officer:

Holdings: 71.63K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--